It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
HLA class II (HLA-II) genes’ polymorphism influences the immune response to Chlamydia trachomatis (Ct), it is considered a sexually transmitted infection. However, associations between HLA-II alleles and Ct-infection have been little explored in humans; this study was thus aimed at determining HLA-DRB1-DQB1 alleles/haplotypes’ effect on Ct-infection outcome in a cohort of Colombian women. Cervical sample DNA was used as template for detecting Ct by PCR and typing HLA-DRB1-DQB1 alleles/haplotypes by Illumina MiSeq sequencing. Survival models were adjusted for identifying the alleles/haplotypes’ effect on Ct-outcome; bioinformatics tools were used for predicting secreted bacterial protein T- and B-cell epitopes. Sixteen HLA-DRB1 alleles having a significant effect on Ct-outcome were identified in the 262 women analysed. DRB1*08:02:01G and DRB1*12:01:01G were related to infection-promoting events. Only the DQB1*05:03:01G allele related to clearance/persistence events was found for HLA-DQB1. HLA-DRB1 allele homozygous women were associated with events having a lower probability of clearance and/or early occurrence of persistence. Twenty-seven peptides predicted in silico were associated with protective immunity against Ct; outer membrane and polymorphic membrane protein-derived peptides had regions having dual potential for being T- or B-cell epitopes. This article describes HLA-DRB1-DQB1 alleles/haplotypes related to Ct-infection resolution and the peptides predicted in silico which might probably be involved in host immune response. The data provides base information for developing future studies leading to the development of effective prevention measures against Ct-infection.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Fundación Instituto de Inmunología de Colombia (FIDIC), Molecular Biology and Immunology Department, Bogotá D.C., Colombia (GRID:grid.418087.2) (ISNI:0000 0004 0629 6527); Universidad Nacional de Colombia, MSc Programme in Microbiology, Bogotá D.C., Colombia (GRID:grid.10689.36) (ISNI:0000 0001 0286 3748)
2 Fundación Instituto de Inmunología de Colombia (FIDIC), Molecular Biology and Immunology Department, Bogotá D.C., Colombia (GRID:grid.418087.2) (ISNI:0000 0004 0629 6527); Universidad de Ciencias Aplicadas y Ambientales (U.D.C.A), Animal Science Faculty, Bogotá D.C., Colombia (GRID:grid.442162.7) (ISNI:0000 0000 8891 6208)
3 Fundación Instituto de Inmunología de Colombia (FIDIC), Molecular Biology and Immunology Department, Bogotá D.C., Colombia (GRID:grid.418087.2) (ISNI:0000 0004 0629 6527); Universidad Nacional de Colombia, Faculty of Medicine, Bogotá D.C., Colombia (GRID:grid.10689.36) (ISNI:0000 0001 0286 3748)
4 Fundación Instituto de Inmunología de Colombia (FIDIC), Molecular Biology and Immunology Department, Bogotá D.C., Colombia (GRID:grid.418087.2) (ISNI:0000 0004 0629 6527)
5 Fundación Instituto de Inmunología de Colombia (FIDIC), Molecular Biology and Immunology Department, Bogotá D.C., Colombia (GRID:grid.418087.2) (ISNI:0000 0004 0629 6527); Universidad Nacional de Colombia, Faculty of Medicine, Bogotá D.C., Colombia (GRID:grid.10689.36) (ISNI:0000 0001 0286 3748); Main Campus, Universidad Santo Tomás, Health Sciences Division, Bogotá D.C., Colombia (GRID:grid.442190.a) (ISNI:0000 0001 1503 9395)